Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
Oct 21, 2024 12:19 HKT | |
|
Everest Medicines' Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
Oct 18, 2024 18:37 HKT | |
|
Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells
Oct 17, 2024 08:00 HKT |  |
|
CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT | |
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT |  |
|
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT |  |
|
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT |  |
|
Hua Medicine Announces 2024 Interim Results
Aug 30, 2024 11:40 HKT | |
|
CanSinoBIO Reports Outstanding H1 2024 Performance
Aug 29, 2024 22:23 HKT | |
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Aug 24, 2024 08:00 HKT |  |
|
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT |  |
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Aug 14, 2024 00:30 HKT |  |
|
Q&M Dental Group's profit after tax grew 84%, Board declared 0.40 cent interim dividend, a 150% increase over the same period last year
Aug 12, 2024 15:00 HKT |  |
|
Dual-action therapy shows promise against aggressive oral cancer
Jul 30, 2024 20:00 HKT |  |
|
CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care
Jul 23, 2024 22:00 HKT |  |
|
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program
Jul 23, 2024 16:00 HKT |  |
|
Q&M Dental Group Advanced "Treatment Plan" AI-Module Released Today
Jul 23, 2024 10:30 HKT | |
|
CGFNS International Announces First Global Credential for Rehab Nurses
Jun 28, 2024 06:00 HKT | |
|
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)
Jun 21, 2024 18:30 HKT | |
|
DC Healthcare's Approve All Resolutions in AGM
Jun 13, 2024 15:00 HKT |  |
|